Mackenzie Financial Corp Has $1.51 Million Stock Position in Amdocs Limited (NASDAQ:DOX)

Mackenzie Financial Corp trimmed its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 14.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,003 shares of the technology company’s stock after selling 3,376 shares during the period. Mackenzie Financial Corp’s holdings in Amdocs were worth $1,514,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Koshinski Asset Management Inc. acquired a new position in Amdocs in the 3rd quarter worth about $41,000. Advisory Services Network LLC acquired a new position in Amdocs in the 2nd quarter worth about $48,000. Rockefeller Capital Management L.P. increased its position in Amdocs by 212.3% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 1,577 shares of the technology company’s stock worth $121,000 after purchasing an additional 1,072 shares during the last quarter. JJJ Advisors Inc. increased its position in Amdocs by 17.7% in the 3rd quarter. JJJ Advisors Inc. now owns 2,269 shares of the technology company’s stock worth $172,000 after purchasing an additional 341 shares during the last quarter. Finally, AGF Investments Inc. acquired a new position in Amdocs in the 2nd quarter worth about $180,000. 87.65% of the stock is currently owned by institutional investors.

Shares of NASDAQ DOX opened at $75.70 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.59 and a current ratio of 1.59. The firm has a market cap of $9.93 billion, a price-to-earnings ratio of 14.28, a P/E/G ratio of 1.58 and a beta of 0.79. The business’s 50-day simple moving average is $73.45 and its 200-day simple moving average is $76.18. Amdocs Limited has a 52 week low of $68.33 and a 52 week high of $82.38.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, November 2nd. The technology company reported $1.16 EPS for the quarter, missing the Zacks’ consensus estimate of $1.18 by ($0.02). The company had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.11 billion. Amdocs had a net margin of 16.05% and a return on equity of 15.52%. During the same period in the prior year, the company posted $1.17 EPS. As a group, equities research analysts forecast that Amdocs Limited will post 4.78 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 28th. Stockholders of record on Friday, December 31st will be issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date of this dividend is Thursday, December 30th. Amdocs’s dividend payout ratio is 27.17%.

Separately, JPMorgan Chase & Co. lowered Amdocs from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $91.00 to $86.00 in a research report on Tuesday, December 14th.

Amdocs Company Profile

Amdocs Ltd. is a holding company, which engages in the provision of software products and services for the communications, entertainment, and media industry service providers. The firm’s offerings are based on a product and services mix, using technologies and methodologies, such as cloud and cloud native, microservices, DevSecOps, low-/no-code, edge computing, open source, bimodal operations, site reliability engineering and increasing amounts of automation through standard information technology tools, open APIs and machine learning and artificial intelligence.

Featured Article: How to start trading in the forex market?

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.